Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in metastatic colorectal cancer
NCT00419159Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in metastatic colorectal cancer (mCRC), sponsored by Novartis. Started Dec 2006; status: completed.
02
Drugs
everolimus
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00419159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00419159.